Clinical Trial Update: Construction of a Recurrence Risk Prediction Model for Liver Resection Based on Drug Sensitivity of Patient-derived Hepatocellular Carcinoma Organoid

View source ↗

Summary

A clinical trial aims to build a recurrence risk prediction model for hepatocellular carcinoma patients undergoing liver resection, using drug sensitivity data …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Shen Feng | Conditions: Hepatocellular Carcinoma | Status: ACTIVE_NOT_RECRUITING